Cologuard Skip the Drama Turns Colon Cancer Screening Into Must-See TV
Cologuard's "Skip the Drama" is a 2025 integrated healthcare campaign created by FCB Health New York, an IPG Health Company, that uses television parody and humor to lower emotional barriers to colon cancer screening among adults in the United States who have historically avoided or delayed the process.
The campaign launched on January 11, 2025, during the NFL playoffs — one of the highest-reach broadcast windows in the United States calendar — with two hero spots that transport viewers into Game of Thrones-style epic fantasy and Real Housewives-style reality television excess. Both scenarios are deliberately overdramatic environments chosen to contrast with the simplicity Cologuard promises. The creative logic is direct: if the drama lives on screen, patients do not need to bring it to their screening decision.
Exact Sciences, the maker of Cologuard, has positioned its at-home stool-DNA test as a less invasive alternative to colonoscopy since the product's commercial launch. "Skip the Drama" extends that positioning by naming the emotional obstacle explicitly — the word "drama" doing double duty as entertainment reference and clinical anxiety shorthand. The campaign ran across sports, news, entertainment, linear television, and streaming, with media handled by OMD, as reported by MediaPost. Digital and social executions were designed as vertical, conversational, bite-sized formats built for feeds rather than simple cutdowns of the television spots, according to pharmalive.com. The Clapboard Score for this campaign is 63 out of 100.
Cologuard addresses a well-documented compliance gap in preventive healthcare in the United States. FCB Health New York built the campaign strategy around several overlapping emotional barriers: anxiety about conversations with healthcare providers, frustration with procedural complexity, absence of a family history that might prompt urgency, and limited access to clinical settings, as documented by pharmalive.com and The One Club. Humor is the chosen mechanism for dissolving each of these barriers without minimising their reality.
The strategic decision to launch during the NFL playoffs is significant. The window delivers broad, demographically diverse reach across the United States at a single moment, placing a preventive health message alongside content that audiences are actively choosing to watch. MediaPost noted that Cologuard's agency and media partner OMD coordinated this placement deliberately to maximise cultural cut-through. The campaign also benefited from pre-existing cultural momentum: as reported by pharmalive.com, late-night hosts and online creators were already incorporating the Cologuard brand character into conversations before the campaign broke, suggesting the brand had achieved a level of cultural legibility that "Skip the Drama" could build on rather than establish from scratch.
Competitively, Cologuard operates in a market where colonoscopy holds approximately 45.95% of the screening-tests market in 2025, according to Grand View Research, while stool-DNA assays are forecast to grow at approximately 11.05% annually through 2031, per the same source. Rival non-invasive screening products, including Guardant Health's Shield blood-based test, are entering the United States market and intensifying category competition. By investing in entertainment-grade creative, FCB Health New York and Cologuard are staking out a brand distinctiveness that clinical messaging alone cannot sustain against an expanding competitor set.
FCB Health New York constructed "Skip the Drama" around two distinct production worlds, each demanding a different visual vocabulary. The Game of Thrones-referencing execution recreates the aesthetic of prestige fantasy television — costuming, castle interiors, and the heightened theatricality of characters delivering weighty pronouncements about fate — before puncturing the moment with the mundane ease of at-home colon cancer screening. The Real Housewives-referencing execution mirrors the colour-saturated, confrontational staging of reality television, a world defined by interpersonal conflict and performative emotion.
Kathleen Nanda, Chief Creative Officer at FCB Health New York, oversaw the creative direction of the campaign. As reported by pharmalive.com, Nanda emphasised that the broader ecosystem supporting the television spots was designed as an original digital and social layer rather than repurposed broadcast content. The vertical, conversational formats distributed across digital feeds were conceived to function as standalone pieces appropriate to their platform context, reflecting a production philosophy in which the TV spots and the digital content are different creative objects built from the same strategic brief.
The "Blizzard" execution received a Bronze for Cinematography at the New York Festivals Health Awards 2025, as confirmed by home.nyfhealth.com, recognising the technical craft invested in recreating a convincing fantasy production environment within a healthcare advertising context. The "White Knights" execution also received recognition at the same awards, per Home Nyfhealth. Production design and art direction across the campaign earned a Gold at the New York Festivals Health Awards 2025, according to home.nyfhealth.com, reflecting the degree to which the visual construction of each parody world was central to the campaign's persuasive effectiveness.
"Skip the Drama" earned the Pharma Grand Award at the New York Festivals Health Awards 2025, the highest honour in that competition, as confirmed by home.nyfhealth.com. This represents a measurable marker of peer-assessed creative excellence within the healthcare advertising industry in the United States.
Beyond the Pharma Grand Award, the campaign accumulated a substantial awards record across the same competition. Home.nyfhealth.com confirms a Gold award for Direct-to-Consumer: Branded Film Commercials, a Gold for Production Design and Art Direction, a Silver for Social Media Single Platform Campaign, a Bronze for Cinematography attributed to the "Blizzard" execution, and additional Bronze recognition for the "White Knights" execution. Natlawreview.com and oneclub.org corroborate the campaign's standing within the 2025 healthcare creative awards cycle.
The "Unreal Screeners" asset connected to the campaign registered approximately 5.76 million views, as noted in platform data cited in the campaign record. No independently verified sales or conversion metrics for the "Skip the Drama" campaign period are publicly available at the time of writing. What the awards record does confirm structurally is that the campaign succeeded on the dimensions that healthcare creative juries evaluate most rigorously: strategic clarity, production quality, and the ability to make a clinically serious subject accessible through a defined creative conceit. For a category where patient inaction carries direct health consequences, the decision to invest in entertainment-grade production and broad-reach media placement reflects a calculated bet that cultural relevance accelerates screening consideration in the United States more effectively than conventional health messaging.
"Skip the Drama" is a 2025 integrated campaign by FCB Health New York for Cologuard. It uses parody of Game of Thrones and Real Housewives to reduce anxiety around colon cancer screening in the United States. Two hero spots launched during the NFL playoffs on January 11, 2025, across linear TV and streaming.
FCB Health New York, an IPG Health Company, created the campaign for Exact Sciences, maker of Cologuard. Kathleen Nanda served as Chief Creative Officer at FCB Health New York. Media was handled by OMD, as reported by MediaPost, with distribution spanning sports, news, entertainment, linear TV, and streaming in the United States.
"Skip the Drama" won the Pharma Grand Award at the New York Festivals Health Awards 2025, according to home.nyfhealth.com. The campaign also received Gold for Direct-to-Consumer Branded Film Commercials, Gold for Production Design and Art Direction, Silver for Social Media, and Bronze awards for the Blizzard and White Knights executions.
Cologuard and FCB Health New York identified humor as the most effective mechanism for addressing emotional barriers including anxiety, frustration, and lack of urgency, as documented by pharmalive.com. Colon cancer screening is a topic many adults in the United States avoid discussing, and entertainment-style parody lowers that resistance without minimising the clinical importance of early detection.
"Skip the Drama" represents a creative evolution rather than a strategic reset, according to clapboard.com. Earlier campaigns including "Go Go Cologuard" used a video-game format to explain the at-home process. "Skip the Drama" retains the at-home screening promise while adding entertainment parody and humor to elevate brand presence in culture across the United States.
Cologuard's "Skip the Drama" campaign receives a Clapboard Score of 63 out of 100. The score reflects strong creative ambition and a well-executed parody concept validated by the 2025 New York Festivals Health Pharma Grand Award, balanced against the absence of publicly verified consumer performance or conversion metrics for the campaign period.
.webp)
Creative Collaboration Platform: The Backbone of Modern Creative WorkWhat is a creative collaboration platform?Clapboard defines a creative collaboration platform as the operational core for today’s distributed creative teams. This is not a collection of digital collaboration tools stitched together; Clapboard’s system
Understanding the Creative Production MarketplaceWhat is a Creative Production Marketplace?Clapboard defines a creative production marketplace as a structured ecosystem where brands, agencies, and production talent converge to execute video, advertising, and branded content at scale. Unlike the legacy agency or freelanREAD FULL ARTICLE
The Urgent Need for a Creative Production Operating SystemWhy Traditional Creative Production Models Break DownClapboard sees the creative production landscape shifting under pressure. Content velocity is no longer a buzzword—it’s a mandate. Modern advertising demands relentless output across dozens of channels, each wREAD FULL ARTICLE
